Accessibility Menu
 

Primemd

(OTC) PRMD

Current Price$0.00
Market Cap$20,600
Since IPO (1990)-99%
5 Year-97%
1 Year+450%
1 Month+57%

Primemd Financials at a Glance

Market Cap

$20,600

Revenue (TTM)

$10.50M

Net Income (TTM)

$3.14M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-17.11 (Low)

Price

$0.00

Volume

2,720

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

PRMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Primemd

Industry

Real Estate Management and Development

CEO

Raymond N. Joeckel

Headquarters

Littleton, CO 80123, US

PRMD Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

40%

Net Income Margin

30%

Return on Equity

0%

Return on Capital

28%

Return on Assets

20%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.60K

Shares Outstanding

18.70M

Volume

2.72K

Avg. Volume

201.905

Financials (TTM)

Gross Profit

$10.50M

Operating Income

$4.16M

EBITDA

$3.43M

Operating Cash Flow

$3.02M

Capital Expenditure

$776.04K

Free Cash Flow

$2.24M

Cash & ST Invst.

$2.59M

Total Debt

$7.13M

Primemd Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2021YOY CHG

Revenue

$1.64M

N/A

Gross Profit

$1.64M

N/A

Gross Margin

100.00%

N/A

Market Cap

$20.60K

N/A

Market Cap/Employee

$20.60K

N/A

Employees

1

N/A

Net Income

$2.63M

N/A

EBITDA

$3.40M

N/A

Quarterly Fundamentals

Name
Q3 2021YOY CHG

Net Cash

$4.54M

N/A

Accounts Receivable

$5.04M

N/A

Inventory

$0.00

N/A

Long Term Debt

$6.89M

N/A

Short Term Debt

$239.28K

N/A

Return on Assets

20.49%

N/A

Return on Invested Capital

27.98%

N/A

Free Cash Flow

$3.82M

N/A

Operating Cash Flow

$4.58M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ITMCItoco Inc.
$0.00+0.00%
ROTHPharmaRoth Labs, Inc.
$0.00+0.00%
DECNDecision Diagnostics Corp.
$0.00+0.00%
AMBSAmarantus BioScience Holdings, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%
NIONio
$5.91-0.08%

Questions About PRMD

What is the current price of Primemd?

Primemd is trading at $0.00 per share.

What is the 52-week range for Primemd?

Over the past 52 weeks, Primemd has traded between $0.00 and $0.00.

How much debt does Primemd have?

As of the most recent reporting period, Primemd reported total debt of $7.13M.

How much cash does Primemd have on hand?

Primemd reported $2.59M in cash and cash equivalents in its most recent financial results.

What is Primemd’s dividend yield?

Primemd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.